Law & Crime: Medical uses and dosages of fentanyl
February 23, 2022
The University of Cincinnati's Dr. Dan Arendt was featured in a Law & Crime television segment on the topic of medical uses of fentanyl.
February 23, 2022
The University of Cincinnati's Dr. Dan Arendt was featured in a Law & Crime television segment on the topic of medical uses of fentanyl.
March 14, 2022
55KRC featured the University of Cincinnati's Dr. Timothy Phoenix on the Simply Medicine program, discussing his research into treatments for diffuse midline glioma, a deadly pediatric brain tumor.
February 4, 2022
Medical Xpress highlighted the work of the University of Cincinnati's Timothy Phoenix and his colleagues who have identified the role of a key gene linked to pediatric diffuse midline gliomas, a deadly brain tumor.
March 23, 2022
The University of Cincinnati's Michael Hegener, PharmD, was featured in a HuffPost article about different health issues pharmacists can help patients with beyond filling prescriptions.
March 10, 2022
The University of Cincinnati's Daniel Arendt, PharmD, examines discriminatory policies throughout the history of U.S. drug policy and how they have led to the stigmatization of patients suffering from painful conditions as "drug seekers."
April 29, 2022
The University of Cincinnati's Jill Boone was featured in a Local 12 story on the impact of staffing issues at local pharmacies.
August 17, 2022
The University of Cincinnati's Michael Hegener, PharmD, was a panelist on WVXU's Cincinnati Edition discussing the under-regulated dietary supplements industry.
September 8, 2022
Radio show and podcast Sunday Morning Magazine featured the Klaserner family of parents John and Lorrie, UC pharmacy alumni, and children Adam and Ally, current students at UC's James L. Winkle College of Pharmacy.
April 7, 2023
Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.
April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.